Skip to main content
Equibles

Jack Stover

Board Member

Transcode Therapeutics, Inc. (RNAZ)

Equibles does not estimate personal net worth.

Get an email with a short summary when Transcode Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get RNAZ alerts

About Jack Stover

Jack Stover is recorded as Board Member at Transcode Therapeutics, Inc. (RNAZ) since December 19, 2025. Transcode Therapeutics, Inc. reported in an 8-K filed December 22, 2025 that Jack Stover was appointed Director, effective December 19, 2025. Transcode Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Transcode Therapeutics, Inc. includes Philippe Calais (CEO), Philippe P. Calais (CEO and Board Member), Thomas A. Fitzgerald (CEO and CFO) and 6 others.

“On December 19, 2025, the Board of Directors (the "Board") of TransCode Therapeutics, Inc., a Delaware corporation (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Jack Stover to the Board, effective December 19, 2025.”
Transcode Therapeutics, Inc. Form 8-K, filed December 22, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Transcode Therapeutics, Inc.

Recent activity